Published in J Addict Behav Ther Rehabil on September 01, 2013
Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals. PLoS One (2015) 0.87
Evaluation of a Web-based tailored intervention (TAVIE en santé) to support people living with HIV in the adoption of health promoting behaviours: an online randomized controlled trial protocol. BMC Public Health (2015) 0.81
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial. J Acquir Immune Defic Syndr (2015) 0.80
Correlates of Adherence to Varenicline Among HIV+ Smokers. Nicotine Tob Res (2015) 0.79
Exposing the gaps in awareness, knowledge and estimation of risk for anal cancer in men who have sex with men living with HIV: a cross-sectional survey in Australia. J Int AIDS Soc (2015) 0.78
Improving Health and Reducing Comorbidity Associated with HIV: The Development of TAVIE en santé, a Web-Based Tailored Intervention to Support the Adoption of Health Promoting Behaviors among People Living with HIV. Biomed Res Int (2017) 0.75
In search of how people change. Applications to addictive behaviors. Am Psychol (1992) 28.48
Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med (2006) 5.49
A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med (2008) 4.57
Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis (2010) 3.79
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr (2007) 3.38
A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS (2006) 2.77
Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis (2007) 2.55
Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res (2005) 2.55
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis (2012) 2.39
Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis (2000) 1.90
Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS (2002) 1.89
Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev (2009) 1.72
Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr (2010) 1.67
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction (2009) 1.61
Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS (2007) 1.55
Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res (2011) 1.51
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med (2006) 1.38
A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav (2007) 1.37
Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care (2013) 1.34
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction (2012) 1.32
The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care (2001) 1.32
A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther (2006) 1.27
A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr (2012) 1.26
Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav (2012) 1.17
A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res (2013) 1.13
Smoking cessation for clients who are HIV-positive. Nurs Stand (2005) 1.10
Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS (2013) 1.01
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS (2011) 0.98
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med (2012) 0.95
Illness representation and smoking behavior: a focus group study of HIV-positive men. J Assoc Nurses AIDS Care (2004) 0.94
Comparison of the role of self-efficacy and illness representations in relation to dietary self-care and diabetes distress in adolescents with type 1 diabetes. Psychol Health (2009) 0.92
Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res (2012) 0.87
HIV and general cardiovascular risk. J Assoc Nurses AIDS Care (2011) 0.87
Depressive symptoms among heavy cigarette smokers: the influence of daily rate, gender, and race. Nicotine Tob Res (2013) 0.84
Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS (2003) 0.84
[Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy]. Enferm Infecc Microbiol Clin (2006) 0.83